斑点征预测血肿扩大及临床结局准确性的Meta分析
该Meta分析纳入26项研究共5085例脑出血患者,评估CT血管成像斑点征预测血肿扩大和死亡率的准确性。斑点征预测血肿扩大的阳性似然比为4.85,阴性似然比为0.49,曲线下面积为0.86;预测死亡率的曲线下面积为0.87。结论认为斑点征有潜力预测血肿扩大和死亡率,但研究间异质性大,应用需谨慎。
要点
- 斑点征预测血肿扩大的阳性似然比4.85,阴性似然比0.49。
- 斑点征预测死亡率的阳性似然比4.65,阴性似然比0.55。
- 斑点征预测血肿扩大和死亡率的曲线下面积分别为0.86和0.87。
核心结论
- 斑点征有潜力预测血肿扩大和死亡率,但研究间异质性大,应用需谨慎。
研究设计与样本
- 检索PubMed、Medline、会议论文集及文章参考文献至2017年6月的英文研究,纳入26项研究共5085例患者。
- 采用双变量随机效应Meta分析计算阳性似然比、阴性似然比及汇总受试者工作特征曲线下面积。
- 血肿扩大定义为体积增加≥6 mL或≥33%。
主要发现
- 斑点征预测血肿扩大的阳性似然比为4.85(95% CI,3.85-6.02;I2=76.1%),阴性似然比为0.49(95% CI,0.40-0.58)。
- 斑点征预测死亡率的阳性似然比为4.65(95% CI,3.67-5.90),阴性似然比为0.55(95% CI,0.40-0.69)。
- 血肿扩大的汇总敏感度为0.57(95% CI,0.49-0.64),汇总假阳性率为0.12(95% CI,0.09-0.14),验后概率为0.57。
- 血肿扩大和死亡率的曲线下面积分别为0.86和0.87(双变量方法未提供置信区间)。
- Meta回归显示敏感度随发表年份显著下降(β=-0.148;95% CI,-0.295至-0.001;P=0.05),质量评估越高假阳性率越低(β=-0.074;95% CI,-0.126至-0.022;P=0.006)。
临床怎么用
- 斑点征可作为脑出血血肿扩大和死亡风险的影像学参考指标,但需结合研究异质性谨慎解读。
局限性
- 研究间存在异质性,斑点征预测血肿扩大的敏感度随发表年份下降,高质量研究假阳性率更低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The computed tomography angiographic spot sign refers to contrast leakage within intracerebral hemorrhage (ICH). It has been proposed as a surrogate radiological marker for ICH growth. We conducted a meta-analysis to study the accuracy of the spot sign for predicting ICH growth and mortality. Methods- PubMed, Medline, conference proceedings, and article references in English up to June 2017 were searched for studies reporting "computed tomography angiography" and "spot sign" or "intracerebral hemorrhage" and "spot sign." Each study was ranked on 27 criteria resulting in a quality rating score. Bivariate random effect meta-analysis was used to calculate positive and negative likelihood ratios and area under summary receiver operating characteristics curve for ICH growth and mortality. Hematoma growth was defined using the change in ≥6 mL or ≥33% increase in volume. Results- There were 26 studies describing 5085 patients, including 15 studies not used in previous meta-analyses. Positive likelihood ratio and negative likelihood ratio for ICH growth were 4.85 (95% CI, 3.85-6.02; I2=76.1%) and 0.49 (95% CI, 0.40-0.58) and mortality were 4.65 (95% CI, 3.67-5.90) and 0.55 (95% CI, 0.40-0.69), respectively. For ICH growth, the pooled sensitivity was 0.57 (95% CI, 0.49-0.64) and pooled false positive rate was 0.12 (95% CI, 0.09-0.14). The post-test probability of ICH growth was 0.57. The area under the curve for ICH growth and mortality was 0.86 and 0.87 (CIs are not provided in bivariate method). Meta-regression showed sensitivity of the test to decline significantly with subsequent year of publication (β=-0.148; 95% CI, -0.295 to -0.001; P=0.05). Higher quality assessment is associated with lower false positive rate (β=-0.074; 95% CI, -0.126 to -0.022; P=0.006). Conclusions- The high area under the curve potentially suggests that the spot sign can predict hematoma growth and mortality. Caution is recommended in its application given the heterogeneity across studies, which is appropriate given the data.
引用
- Phan TG, Krishnadas N, Lai VWY, et al. Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes. Stroke. 2019. PMID: 31272327. doi:10.1161/STROKEAHA.118.024347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。